3D InSight™ 14 Day Hepatoxicity Testing – ATP (DILI Service)

Assesses effect of compounds on cellular viability in 3D InSight™ Human Liver Microtissues using an ATP assay endpoint. 

Standard service includes: 7-point dose response curve, 7- or 14-day repeat dose protocol, cell viability endpoint, and a service summary report. 

Turnaround time: 3-4 weeks.

Vendor: InSphero AG